NCT06734988

Brief Summary

Background: Acute respiratory distress syndrome (ARDS) patients require careful assessment before extubation to prevent failure, which is associated with poor outcomes. While current guidelines recommend weaning protocols, these are based on general respiratory failure studies rather than ARDS-specific data. Esophageal pressure (Pes) measurement provides direct assessment of inspiratory effort but is rarely utilized clinically. Objectives: This Japanese sub-study of EXTEND ARDS aims to evaluate whether:

  1. 1.ΔPes measurements during spontaneous breathing trials (SBT) can predict SBT failure
  2. 2.ΔPes measurements post-extubation can predict 48-hour extubation failure

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Dec 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Dec 2024Feb 2027

First Submitted

Initial submission to the registry

December 4, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

December 4, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

2.1 years

First QC Date

December 4, 2024

Last Update Submit

December 10, 2024

Conditions

Keywords

Esophageal pressureSBT

Outcome Measures

Primary Outcomes (1)

  • Reintubation within 48 hours after extubation

    Occurrence of reintubation events within 48 hours after planned extubation

    48 hours after extubation

Secondary Outcomes (1)

  • SBT Failure

    Up to 120 minutes from the start of spontaneous breathing trial

Other Outcomes (1)

  • 90 days in-hospital mortality

    From intubation to 90 days after intubation

Study Arms (1)

Mechanically ventilated adult ARDS patients

Adult mechanically ventilated patients (≥ 16 years old) with esophageal pressure monitoring, expected to receive invasive mechanical ventilator for more than 48 hours

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult mechanically ventilated patients (≥ 16 years old) expected to receive invasive mechanical ventilator for more than 48 hours

You may qualify if:

  • Adult mechanically ventilated patients (≥ 16 years old) with esophageal pressure monitoring, expected to receive invasive mechanical ventilator for more than 48 hours
  • Patients who meet the diagnosis of ARDS at the start of invasive mechanical ventilation based on a new global definition of ARDS.

You may not qualify if:

  • Patients who already had tracheostomy at the start of invasive mechanical ventilation
  • Patients who were transferred to participating hospital more than 2 days after the start of invasive mechanical ventilation
  • Patients with terminal conditions at the start of invasive mechanical ventilation
  • Patients who have expressed their refusal to have their clinical data used in research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sapporo Medical University

Sapporo, Hokkaido, 060-8556, Japan

RECRUITING

MeSH Terms

Conditions

Acute Lung Injury

Condition Hierarchy (Ancestors)

Lung InjuryLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2024

First Posted

December 16, 2024

Study Start

December 4, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

February 28, 2027

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Study protocol

Shared Documents
STUDY PROTOCOL

Locations